BlackRock Fund Advisors’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$62.1M	Buy	1,921,554 +239,173	+14%	+$7.98M	0.01%	1541
2016 Q3	$57.6M	Buy	1,682,381 +90,693	+6%	+$3.55M	0.01%	1481
2016 Q2	$53.7M	Buy	1,591,688 +9,454	+0.6%	+$465K	0.01%	1441
2016 Q1	$83.8M	Buy	1,582,234 +18,120	+1%	+$1.06M	0.02%	1102
2015 Q4	$120M	Sell	1,564,114 -94,879	-6%	-$5.37M	0.03%	813
2015 Q3	$68.2M	Buy	1,658,993 +29,805	+2%	+$1.83M	0.02%	1218
2015 Q2	$115M	Buy	1,629,188 +20,337	+1%	+$1.6M	0.03%	869
2015 Q1	$143M	Buy	1,608,851 +83,449	+5%	+$8.47M	0.03%	706
2014 Q4	$135M	Buy	1,525,402 +145,926	+11%	+$13.8M	0.03%	702
2014 Q3	$134M	Buy	1,379,476 +24,952	+2%	+$2.43M	0.04%	634
2014 Q2	$124M	Buy	1,354,524 +117,888	+10%	+$8.98M	0.04%	715
2014 Q1	$86.6M	Buy	1,236,636 +30,179	+3%	+$2.05M	0.03%	967
2013 Q4	$69.4M	Buy	1,206,457 +3,235	+0.3%	+$170K	0.02%	1149
2013 Q3	$57.8M	Buy	1,203,222 +142,024	+13%	+$5.18M	0.02%	1213
2013 Q2	$30.8M	Buy	+1,061,198	New	+$30.7M	0.01%	1539